Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36 GBX | 0.00% | 0.00% | -21.74% |
May. 15 | Creo Medical on track to break even next year on strong 2023 results | AN |
May. 15 | Creo Medical Group PLC Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2023 | 30.8M 39.24M | Sales 2024 * | 39.62M 50.48M | Capitalization | 125M 160M |
---|---|---|---|---|---|
Net income 2023 | -21M -26.76M | Net income 2024 * | -13M -16.56M | EV / Sales 2023 | 5.2 x |
Net cash position 2023 * | 22.03M 28.07M | Net cash position 2024 * | 132K 168K | EV / Sales 2024 * | 3.16 x |
P/E ratio 2023 |
-6.57
x | P/E ratio 2024 * |
-9.57
x | Employees | 279 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 79.14% |
Current month | -1.37% | ||
1 month | +1.98% | ||
3 months | -4.00% | ||
6 months | -1.37% | ||
Current year | -21.74% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | - | |
Craig Gulliford
CEO | Chief Executive Officer | - | 11-12-31 |
President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Spicer
CHM | Chairman | 59 | 16-06-30 |
John Bradshaw
BRD | Director/Board Member | 60 | - |
Craig Gulliford
CEO | Chief Executive Officer | - | 11-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 36 | 0.00% | 140 079 |
24-06-10 | 36 | -1.37% | 340,166 |
24-06-07 | 36.5 | +1.39% | 336,335 |
24-06-06 | 36 | 0.00% | 288,247 |
24-06-05 | 36 | 0.00% | 301,280 |
Delayed Quote London S.E., June 11, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.74% | 160M | |
-24.52% | 7.29B | |
+5.90% | 6.75B | |
+18.57% | 5.5B | |
-18.64% | 4.75B | |
+18.17% | 4.1B | |
-20.73% | 3.93B | |
-26.34% | 2.7B | |
+43.10% | 2.31B | |
+1.86% | 2.06B |
- Stock Market
- Equities
- CREO Stock